As of 30 Sep 2025, 93 institutional investors reported holding 19,565,976 shares of CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC). This represents 87% of the company’s total 22,421,536 outstanding shares.
The largest institutional shareholders of CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) together control 78% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| GLAZER CAPITAL, LLC | 20% | 4,546,634 | +664% | 0.82% | $24,506,000 |
| ALPINE ASSOCIATES MANAGEMENT INC. | 10% | 2,295,422 | +16% | 0.75% | $12,372,325 |
| Qube Research & Technologies Ltd | 7.6% | 1,712,737 | +45% | 0.01% | $9,231,652 |
| BlackRock, Inc. | 4.5% | 1,016,297 | -1.4% | 0% | $5,477,841 |
| AQR Arbitrage LLC | 4.4% | 991,688 | +2146% | 0.14% | $5,345,198 |
| WATER ISLAND CAPITAL LLC | 3.4% | 762,138 | -20% | 0.59% | $4,107,924 |
| Magnetar Financial LLC | 2.9% | 654,796 | 0.02% | $3,529,350 | |
| ROYAL BANK OF CANADA | 2.2% | 501,610 | +5107% | 0% | $2,703,000 |
| Bridgewater Associates, LP | 2.1% | 466,407 | 0.01% | $2,513,934 | |
| BANK OF AMERICA CORP /DE/ | 2% | 443,324 | +364% | 0% | $2,389,516 |
| UBS Group AG | 1.8% | 401,269 | +66% | 0% | $2,162,840 |
| GOLDMAN SACHS GROUP INC | 1.8% | 399,893 | -7.8% | 0% | $2,155,423 |
| NORTHERN TRUST CORP | 1.6% | 354,694 | -9.5% | 0% | $1,911,800 |
| BNP PARIBAS FINANCIAL MARKETS | 1.5% | 330,515 | 0% | 0% | $1,781,476 |
| JPMORGAN CHASE & CO | 1.3% | 301,521 | -4% | 0% | $1,625,199 |
| CSS LLC/IL | 1.2% | 273,495 | 0.09% | $1,474,138 | |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | 1.2% | 258,116 | 0.01% | $1,391,245 | |
| DEUTSCHE BANK AG\ | 1.1% | 255,783 | +19% | 0% | $1,378,671 |
| Carmignac Gestion | 1% | 235,180 | +172% | 0.02% | $1,267,620 |
| GEODE CAPITAL MANAGEMENT, LLC | 1% | 226,497 | -8% | 0% | $1,220,818 |
| CITIGROUP INC | 0.97% | 216,875 | +352% | 0% | $1,168,957 |
| MORGAN STANLEY | 0.93% | 207,696 | +73% | 0% | $1,119,480 |
| Swiss National Bank | 0.86% | 193,579 | 0% | 0% | $1,034,787 |
| Amundi | 0.82% | 183,856 | +34% | 0% | $994,661 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.67% | 150,428 | 0% | $810,286 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 333,672 | $1,351,918 | -$17,812,031 | $4.52 | 19 |
| 2025 Q3 | 19,565,976 | $105,428,086 | +$42,943,344 | $5.39 | 93 |
| 2025 Q2 | 11,518,381 | $62,488,985 | +$21,426,773 | $5.43 | 88 |
| 2025 Q1 | 7,872,317 | $21,841,913 | -$777,543 | $2.77 | 81 |
| 2024 Q4 | 7,855,201 | $26,621,771 | -$5,836,624 | $3.41 | 74 |
| 2024 Q3 | 11,129,364 | $32,809,500 | -$7,039,565 | $2.94 | 78 |
| 2024 Q2 | 14,229,273 | $48,278,571 | -$9,342,638 | $3.40 | 85 |
| 2024 Q1 | 15,940,182 | $48,278,751 | -$19,660,440 | $3.03 | 88 |
| 2023 Q4 | 22,199,014 | $93,446,194 | -$57,799,701 | $4.21 | 88 |
| 2023 Q3 | 33,716,537 | $230,128,246 | -$14,892,714 | $6.83 | 84 |
| 2023 Q2 | 35,746,141 | $372,596,379 | -$7,716,451 | $10.42 | 86 |
| 2023 Q1 | 36,701,197 | $255,777,503 | +$175,104,339 | $6.97 | 81 |
| 2022 Q4 | 11,606,048 | $70,002,654 | +$26,244,613 | $6.03 | 79 |
| 2022 Q3 | 7,148,145 | $56,407,292 | -$15,368,475 | $7.88 | 76 |
| 2022 Q2 | 8,406,419 | $114,404,583 | -$92,528,445 | $13.61 | 79 |
| 2022 Q1 | 14,444,471 | $283,158,200 | -$10,020,593 | $19.61 | 103 |
| 2021 Q4 | 14,649,709 | $503,022,059 | +$22,422,488 | $34.31 | 99 |
| 2021 Q3 | 13,728,835 | $749,897,430 | -$11,662,295 | $54.62 | 104 |
| 2021 Q2 | 10,743,822 | $789,319,360 | -$28,307,983 | $73.48 | 104 |
| 2021 Q1 | 14,053,252 | $1,284,956,347 | +$337,575,946 | $91.46 | 83 |
| 2020 Q4 | 7,249,066 | $588,215,271 | -$18,687,692 | $81.07 | 58 |
| 2020 Q3 | 7,605,083 | $355,419,000 | +$354,563,000 | $46.55 | 42 |
| 2020 Q2 | 108 | $8,000 | $74.07 | 1 | |
| 2020 Q1 | 108 | $8,000 | $74.07 | 1 | |
| 2019 Q4 | 108 | $8,000 | $74.07 | 1 | |
| 2019 Q3 | 108 | $8,000 | $74.07 | 1 | |
| 2019 Q2 | 108 | $8,000 | $74.07 | 1 | |
| 2019 Q1 | 108 | $8,000 | $74.07 | 1 |